Lam Research Corporation $LRCX Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC trimmed its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 3.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 517,078 shares of the semiconductor company’s stock after selling 20,270 shares during the period. Nisa Investment Advisors LLC’s holdings in Lam Research were worth $69,371,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. IMG Wealth Management Inc. acquired a new stake in Lam Research during the second quarter worth about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Lam Research during the 2nd quarter worth approximately $27,000. Sound Income Strategies LLC bought a new stake in shares of Lam Research in the 3rd quarter worth approximately $41,000. Tripletail Wealth Management LLC acquired a new position in Lam Research during the 3rd quarter valued at approximately $44,000. Finally, Strategic Wealth Investment Group LLC acquired a new position in Lam Research during the 2nd quarter valued at approximately $29,000. 84.61% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the transaction, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 102,608 shares of company stock valued at $14,916,496. Insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

NASDAQ:LRCX opened at $200.96 on Friday. The company has a 50-day moving average of $164.77 and a 200-day moving average of $131.92. The firm has a market cap of $252.41 billion, a price-to-earnings ratio of 44.26, a price-to-earnings-growth ratio of 2.34 and a beta of 1.77. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $210.45.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business’s quarterly revenue was up 27.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were paid a dividend of $0.26 per share. The ex-dividend date of this dividend was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on LRCX shares. TD Cowen increased their target price on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Oppenheimer set a $200.00 price objective on shares of Lam Research and gave the stock an “outperform” rating in a report on Thursday, October 23rd. Citigroup boosted their target price on shares of Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. Cowen restated a “buy” rating on shares of Lam Research in a research report on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Lam Research from $160.00 to $195.00 and gave the company a “buy” rating in a research note on Friday, December 19th. Twenty-six analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Lam Research presently has an average rating of “Moderate Buy” and an average price target of $163.04.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.